Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

The Company continues to engage with convertible bondholders and right-size the capital structure through these exchanges ... improvement in the primary endpoint of event-free... at 10:35 KEYTRUDA® ...

Since the beginning of our journey, one question has come up often: "How many people are on your team?" This curiosity is especially relevant in our industry, where we're building the best-in-class AI ...

AI and biophysics are revolutionizing cancer treatment by predicting protein binding sites for personalized therapies.

The mostly fixed cost structure allows the company to expand ... Iovance is testing lifileucel in combination with Merck cancer drug Keytruda to treat advanced melanoma. Lifileucel is also in ...

Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in ...

The overall response rate was significantly higher for Keytruda plus chemotherapy versus chemotherapy alone (52% versus 29%). The approval marks first indication for Keytruda in MPM in the US ...

At the European Society for Medical Oncology Congress on September 13–17, promising results from the Phase III KEYNOTE-522 study involving MSD's neoadjuvant Keytruda (pembrolizumab) plus ...

Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...

Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on findings from the KEYNOTE-483 trial. The Food and Drug Administration (FDA) ...